BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25016224)

  • 1. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
    Poynard T; Vergniol J; Ngo Y; Foucher J; Thibault V; Munteanu M; Merrouche W; Lebray P; Rudler M; Deckmyn O; Perazzo H; Thabut D; Ratziu V; de Ledinghen V;
    J Hepatol; 2014 Nov; 61(5):994-1003. PubMed ID: 25016224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
    Poynard T; Vergniol J; Ngo Y; Foucher J; Munteanu M; Merrouche W; Colombo M; Thibault V; Schiff E; Brass CA; Albrecht JK; Rudler M; Deckmyn O; Lebray P; Thabut D; Ratziu V; de Ledinghen V; ; ;
    J Hepatol; 2014 Apr; 60(4):706-14. PubMed ID: 24291240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis.
    Vermehren J; Polta A; Zimmermann O; Herrmann E; Poynard T; Hofmann WP; Bojunga J; Sarrazin C; Zeuzem S; Friedrich-Rust M
    Liver Int; 2012 May; 32(5):852-8. PubMed ID: 22222050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.
    Ngo Y; Benhamou Y; Thibault V; Ingiliz P; Munteanu M; Lebray P; Thabut D; Morra R; Messous D; Charlotte F; Imbert-Bismut F; Bonnefont-Rousselot D; Moussalli J; Ratziu V; Poynard T
    PLoS One; 2008 Jul; 3(7):e2573. PubMed ID: 18596917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis.
    Calvaruso V; Bronte F; Conte E; Simone F; Craxì A; Di Marco V
    J Viral Hepat; 2013 Dec; 20(12):867-74. PubMed ID: 24304456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
    Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
    Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
    Lok AS
    Gastroenterol Clin Biol; 2009; 33(10-11):911-5. PubMed ID: 19577871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
    Poynard T; Munteanu M; Deckmyn O; Ngo Y; Drane F; Castille JM; Housset C; Ratziu V; Imbert-Bismut F
    J Hepatol; 2012 Sep; 57(3):541-8. PubMed ID: 22612998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
    Park MS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Shin SH; Kang W; Moon C; Han KH
    Liver Int; 2015 Feb; 35(2):455-62. PubMed ID: 25183426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.
    Viganò M; Paggi S; Lampertico P; Fraquelli M; Massironi S; Ronchi G; Rigamonti C; Conte D; Colombo M
    Aliment Pharmacol Ther; 2011 Aug; 34(3):353-62. PubMed ID: 21631559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1762-9. PubMed ID: 23808759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
    Halfon P; Munteanu M; Poynard T
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):22-39. PubMed ID: 18973844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.